Link to the University of Pittsburgh Homepage
Link to the University Library System Homepage Link to the Contact Us Form

Dysregulation of the norepinephrine transporter sustains cortical hypodopaminergia and schizophrenialike behaviors in neuronal rictor null mice

Siuta, MA and Robertson, SD and Kocalis, H and Saunders, C and Gresch, PJ and Khatri, V and Shiota, C and Philip Kennedy, J and Lindsley, CW and Daws, LC and Polley, DB and Veenstra-Vanderweele, J and Stanwood, GD and Magnuson, MA and Niswender, KD and Galli, A (2010) Dysregulation of the norepinephrine transporter sustains cortical hypodopaminergia and schizophrenialike behaviors in neuronal rictor null mice. PLoS Biology, 8 (6). ISSN 1544-9173

Published Version
Available under License : See the attached license file.

Download (504kB) | Preview
[img] Plain Text (licence)
Available under License : See the attached license file.

Download (1kB)


The mammalian target of rapamycin (mTOR) complex 2 (mTORC2) is a multimeric signaling unit that phosphorylates protein kinase B/Akt following hormonal and growth factor stimulation. Defective Akt phosphorylation at the mTORC2-catalyzed Ser473 site has been linked to schizophrenia. While human imaging and animal studies implicate a fundamental role for Akt signaling in prefrontal dopaminergic networks, the molecular mechanisms linking Akt phosphorylation to specific schizophrenia-related neurotransmission abnormalities have not yet been described. Importantly, current understanding of schizophrenia suggests that cortical decreases in DA neurotransmission and content, defined here as cortical hypodopaminergia, contribute to both the cognitive deficits and the negative symptoms characteristic of this disorder. We sought to identify a mechanism linking aberrant Akt signaling to these hallmarks of schizophrenia. We used conditional gene targeting in mice to eliminate the mTORC2 regulatory protein rictor in neurons, leading to impairments in neuronal Akt Ser473 phosphorylation. Rictor-null (KO) mice exhibit prepulse inhibition (PPI) deficits, a schizophrenia-associated behavior. In addition, they show reduced prefrontal dopamine (DA) content, elevated cortical norepinephrine (NE), unaltered cortical serotonin (5-HT), and enhanced expression of the NE transporter (NET). In the cortex, NET takes up both extracellular NE and DA. Thus, we propose that amplified NET function in rictor KO mice enhances accumulation of both NE and DA within the noradrenergic neuron. This phenomenon leads to conversion of DA to NE and ultimately supports both increased NE tissue content as well as a decrease in DA. In support of this hypothesis, NET blockade in rictor KO mice reversed cortical deficits in DA content and PPI, suggesting that dysregulation of DA homeostasis is driven by alteration in NET expression, which we show is ultimately influenced by Akt phosphorylation status. These data illuminate a molecular link, Akt regulation of NET, between the recognized association of Akt signaling deficits in schizophrenia with a specific mechanism for cortical hypodopaminergia and hypofunction. Additionally, our findings identify Akt as a novel modulator of monoamine homeostasis in the cortex. © 2010 Siuta et al.


Social Networking:
Share |


Item Type: Article
Status: Published
CreatorsEmailPitt UsernameORCID
Siuta, MA
Robertson, SD
Kocalis, H
Saunders, C
Gresch, PJ
Khatri, V
Shiota, Cchs94@pitt.eduCHS94
Philip Kennedy, J
Lindsley, CW
Daws, LC
Polley, DB
Veenstra-Vanderweele, J
Stanwood, GD
Magnuson, MA
Niswender, KD
Galli, A
ContributionContributors NameEmailPitt UsernameORCID
Date: 1 June 2010
Date Type: Publication
Journal or Publication Title: PLoS Biology
Volume: 8
Number: 6
DOI or Unique Handle: 10.1371/journal.pbio.1000393
Refereed: Yes
ISSN: 1544-9173
MeSH Headings: Animals; Carrier Proteins--genetics; Carrier Proteins--physiology; Dopamine--metabolism; Mice; Mice, Knockout; Norepinephrine Plasma Membrane Transport Proteins--physiology; Phosphorylation; Prefrontal Cortex--metabolism; Proto-Oncogene Proteins c-akt--chemistry; Proto-Oncogene Proteins c-akt--metabolism; Schizophrenia--physiopathology; Serine--metabolism; Signal Transduction; Trans-Activators--metabolism
Other ID: NLM PMC2882427
PubMed Central ID: PMC2882427
PubMed ID: 20543991
Date Deposited: 03 Aug 2012 20:57
Last Modified: 05 Feb 2019 14:55


Monthly Views for the past 3 years

Plum Analytics

Actions (login required)

View Item View Item